Afatinib in combination with GEMOX chemotherapy as the adjuvant treatment in patients with ErbB pathway mutated, resectable gallbladder cancer: study protocol for a ctDNA-based, multicentre, open-label, randomised, controlled, phase II trial.
BMJ open（2023）
摘要
NCT04183712.
更多查看译文
关键词
cancer genetics,chemotherapy,gastrointestinal tumours,hepatobiliary surgery
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要